Literature DB >> 23621426

Amyotrophic lateral sclerosis/motor neuron disease deaths in the United States, 1999-2009.

Jason M Mehal1, Robert C Holman, Lawrence B Schonberger, James J Sejvar.   

Abstract

Our objective was to examine trends and epidemiology of amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) associated deaths in the United States. ALS/MND associated death rates and trends in the United States for 1999-2009 were examined using the multiple cause-of-death mortality data. Age-specific and age-adjusted death rates were calculated. For 1999-2009, the average annual age-adjusted death rate was 2.17/100,000 persons. The age-specific rate increased with age until 75-79 years. Males experienced a higher death rate than females. There was no definitive trend in the annual ALS/MND associated death rate, although analyses suggested a possible decrease (p = 0.05); however, the rate increased for persons 20-49 years of age and declined for persons ≥ 65 years of age. The annual rate for males decreased whereas the rate for females showed no change. In conclusion, the suggested decreasing annual ALS/MND associated death rate for 1999-2009 contrasts with earlier reports indicating that the incidence and death rate of ALS were increasing. While the ALS/MND associated death rate slightly increased among adults 20-49 years of age, rates declined among two subpopulations at higher risk for ALS/MND--males and persons ≥ 65 years of age. Continued monitoring of ALS/MND mortality data and additional epidemiological studies will be important to further elucidate these epidemiological trends.

Entities:  

Mesh:

Year:  2013        PMID: 23621426     DOI: 10.3109/21678421.2013.787629

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  11 in total

Review 1.  The epidemiology of ALS: a conspiracy of genes, environment and time.

Authors:  Ammar Al-Chalabi; Orla Hardiman
Journal:  Nat Rev Neurol       Date:  2013-10-15       Impact factor: 42.937

2.  Amyotrophic Lateral Sclerosis Mortality in the United States, 2011-2014.

Authors:  Theodore C Larson; Wendy Kaye; Paul Mehta; D Kevin Horton
Journal:  Neuroepidemiology       Date:  2018-07-10       Impact factor: 3.282

3.  Survival and Cause of Death among a Cohort of Confirmed Amyotrophic Lateral Sclerosis Cases.

Authors:  Susan T Paulukonis; Eric M Roberts; Jhaqueline P Valle; Natalie N Collins; Paul B English; Wendy E Kaye
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

4.  Effects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behavior.

Authors:  Yun Kyung Hahn; Elizabeth M Podhaizer; Sean P Farris; Michael F Miles; Kurt F Hauser; Pamela E Knapp
Journal:  Brain Struct Funct       Date:  2013-12-19       Impact factor: 3.270

5.  Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients.

Authors:  Christian Burkhardt; Christoph Neuwirth; Andreas Sommacal; Peter M Andersen; Markus Weber
Journal:  PLoS One       Date:  2017-05-23       Impact factor: 3.240

6.  Trends in incidence, prevalence, and mortality of neuromuscular disease in Ontario, Canada: A population-based retrospective cohort study (2003-2014).

Authors:  Louise Rose; Douglas McKim; David Leasa; Mika Nonoyama; Anu Tandon; Yu Qing Bai; Reshma Amin; Sherri Katz; Roger Goldstein; Andrea Gershon
Journal:  PLoS One       Date:  2019-03-26       Impact factor: 3.240

7.  Racial and ethnic differences among amyotrophic lateral sclerosis cases in the United States.

Authors:  Lindsay Rechtman; Heather Jordan; Laurie Wagner; D Kevin Horton; Wendy Kaye
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-12-08       Impact factor: 4.092

8.  Long-term physical activity: an exogenous risk factor for sporadic amyotrophic lateral sclerosis?

Authors:  Ceryl A Harwood; Kate Westgate; Sue Gunstone; Soren Brage; Nicholas J Wareham; Christopher J McDermott; Pamela J Shaw
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2016-03-21       Impact factor: 4.092

9.  Military Service and Amyotrophic Lateral Sclerosis in a Population-based Cohort.

Authors:  Marc G Weisskopf; Merit E Cudkowicz; Norman Johnson
Journal:  Epidemiology       Date:  2015-11       Impact factor: 4.822

10.  A Temporal Association between Accumulated Petrol (Gasoline) Lead Emissions and Motor Neuron Disease in Australia.

Authors:  Mark A S Laidlaw; Dominic B Rowe; Andrew S Ball; Howard W Mielke
Journal:  Int J Environ Res Public Health       Date:  2015-12-19       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.